Filing Details

Accession Number:
0001827506-24-000076
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-08-22 16:22:14
Reporting Period:
2024-08-21
Accepted Time:
2024-08-22 16:22:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1827506 Tourmaline Bio Inc. TRML Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1945691 Chidambar Sandeep Kulkarni C/O Tourmaline Bio, Inc.
27 West 24Th Street, Suite 702
New York NY 10010
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-08-21 1,779 $14.85 7,000 No 4 P Indirect By Gilead Capital, LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Gilead Capital, LP
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.82 to $14.88 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. These shares are held by Gilead Capital, LP ("Gilead"). The Reporting Person's spouse is a partner of Gilead and shares voting and investment power with respect to the shares held by Gilead, and therefore the Reporting Person may be deemed an indirect beneficial owner of these shares. This report is not an admission that the Reporting Person is an indirect beneficial owner of these shares for purposes of Section 16 or for any other purpose.